rs115380062
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_004366.6(CLCN2):āc.1981T>Cā(p.Ser661Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,613,642 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S661T) has been classified as Likely benign.
Frequency
Consequence
NM_004366.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLCN2 | NM_004366.6 | c.1981T>C | p.Ser661Pro | missense_variant | 17/24 | ENST00000265593.9 | NP_004357.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLCN2 | ENST00000265593.9 | c.1981T>C | p.Ser661Pro | missense_variant | 17/24 | 1 | NM_004366.6 | ENSP00000265593.4 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152132Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251298Hom.: 1 AF XY: 0.0000736 AC XY: 10AN XY: 135844
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461510Hom.: 1 Cov.: 36 AF XY: 0.0000289 AC XY: 21AN XY: 727096
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152132Hom.: 0 Cov.: 31 AF XY: 0.000121 AC XY: 9AN XY: 74312
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 07, 2023 | The c.1981T>C (p.S661P) alteration is located in exon 17 (coding exon 17) of the CLCN2 gene. This alteration results from a T to C substitution at nucleotide position 1981, causing the serine (S) at amino acid position 661 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at